Department of Cardiovascular Surgery, Ankara City Hospital, Ankara, Turkey.
Department of Cardiovascular Surgery, VM Medicalpark Hospital, Ankara, Turkey.
BMC Cardiovasc Disord. 2021 Nov 19;21(1):551. doi: 10.1186/s12872-021-02366-y.
To evaluate the value of Glasgow Aneurysm Score (GAS) in predicting long-term mortality and survival in patients who have undergone endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA).
A retrospective single-center study of 257 patients with non-ruptured AAA undergoing EVAR between January 2013 and 2021. GAS scores were compared between the survivors (group 1) and the long-term mortality (group 2) groups. Cox regression analysis was used to determine independent predictors of late mortality. Receiver operating characteristic curve (ROC) analysis was used to determine the optimum cut-off values of GAS values to determine the effect on late-mortality. Survival analysis was conducted using Kaplan-Meier.
The study included 257 patients with a mean age of 69.75 ± 7.75 (46-92), who underwent EVAR due to AAA. Average follow up period was 18.98 ± 22.84 months (0-88). Fourty-five (17.8%) mortalities occured during long-term follow-up. A past medical history of cancer resulted in a 2.5 fold increase in risk of long-term mortality (OR: 2.52, 95% CI 1.10-5.76; p = 0.029). GAS values were higher in group 2 compared to group 1 (81.02 ± 10.33 vs. 73.73 ± 10.46; p < 0.001). The area under the ROC curve for GAS was 0.682 and the GAS cut-off value was 77.5 (specificity 64%, p < 0.001). The mortality rates in patients with GAS < 77.5 and GAS > 77.5 were: 12.8% and 24.8% respectively (p = 0.014). Every 10 point increase in GAS resulted in approximately a 2 fold increase in risk of long-term mortality (OR: 1.8, 95% CI 1.3-2.5; p < 0.001). Five year survival rates in patients with GAS < 77.5 and > 77.5 were 75.7% and 61.7%, respectively (p = 0.013).
The findings of our study suggests that an increase in GAS score may predict long-term mortality. In addition, the mortality rates in patients above the GAS cut-off value almost doubled compared to those below. Furthermore, the presence of a past history of cancer resulted in a 2.5 fold increase in long-term mortality risk. Addition of cancer to the GAS scoring system may be considered in future studies. Further studies are necessary to consolidate these findings.
评估格拉斯哥动脉瘤评分(GAS)在预测接受腹主动脉瘤腔内修复术(EVAR)治疗的患者长期死亡率和生存的价值。
这是一项回顾性单中心研究,纳入了 2013 年 1 月至 2021 年期间接受 EVAR 治疗的 257 例非破裂性腹主动脉瘤患者。比较了幸存者(第 1 组)和长期死亡率(第 2 组)组之间的 GAS 评分。采用 Cox 回归分析确定晚期死亡率的独立预测因素。使用接收者操作特征曲线(ROC)分析确定 GAS 值的最佳截断值,以确定其对晚期死亡率的影响。使用 Kaplan-Meier 进行生存分析。
该研究纳入了 257 例平均年龄 69.75±7.75(46-92)岁、因腹主动脉瘤接受 EVAR 的患者。平均随访时间为 18.98±22.84 个月(0-88)。在长期随访中,有 45 例(17.8%)发生死亡。有癌症既往史的患者发生长期死亡的风险增加 2.5 倍(OR:2.52,95%CI 1.10-5.76;p=0.029)。与第 1 组相比,第 2 组的 GAS 值更高(81.02±10.33 比 73.73±10.46;p<0.001)。GAS 的 ROC 曲线下面积为 0.682,GAS 截断值为 77.5(特异性 64%,p<0.001)。GAS<77.5 和 GAS>77.5 的患者死亡率分别为 12.8%和 24.8%(p=0.014)。GAS 每增加 10 分,长期死亡风险增加约 2 倍(OR:1.8,95%CI 1.3-2.5;p<0.001)。GAS<77.5 和 GAS>77.5 的患者 5 年生存率分别为 75.7%和 61.7%(p=0.013)。
本研究结果表明,GAS 评分的升高可能预测长期死亡率。此外,高于 GAS 截断值的患者死亡率几乎是低于该值的患者的两倍。此外,癌症既往史使长期死亡风险增加 2.5 倍。在未来的研究中,可以考虑将癌症纳入 GAS 评分系统。需要进一步的研究来证实这些发现。